Purpose.​ The purpose of this review was to provide the reader with detailed information
about the history of the development, pharmacokinetics, pharmacodynamics and …

Buspirone, a nonbenzodiasepine anxiolytic, is a partial serotonin 5-HT1A-receptor agonist,
D2-autoreceptor antagonist and low affinity 5-HT2-receptor agonist. This medication is used …

Buspirone is a representative of an innovative class of anxiolytics (non-benzodiazepine
series), used for monotherapy or as part of combined therapy with antidepressants for …

Буспирон—небензодиазепиновый анксиолитик, является селективным парциальным
агонистом серотониновых 5-HT1A-рецепторов, селективным антагонистом …

The main aspects of the recent development of non-benzodiazepine anxiolytic drugs are the
following: the possibility of giving drugs with peculiar anxioselective profile and with no …

Synopsis Buspirone is an anxiolytic agent from the azapirone class of compounds. It differs
structurally and pharmacologically from the benzodiazepines. Although the exact anxiolytic …

Среди пациентов общей практики тревожные расстройства относятся к наиболее
распространённым. Изучена эффективность и безопасность буспирона у пациентов с …

This literature review addresses two related questions: Is buspironc as clinically effective an
antianxiety agent as the benzodiazepines? And docs buspironc offer any safety …

Представлен обзор современных публикаций, посвященных эпидемиологии,
психопатологии, диагностическим критериям, коморбидности наиболее часто …

Buspirone (Buspar) is a azaspirodecanedione anxiolytic agent. Its mechanism of action is
extremely complex, but current investigations indicate that its main neuropharmacologic …